Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that more research is needed to fully understand the causes of PCOS.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Berberine may reduce prostate enlargement by blocking inflammation.

BeauTop helps hair grow by increasing certain growth factors.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.